Gilead Sciences, Inc. agreed to collaborate on the Strata Precision Indications for Approved THerapies (PATH) trial by providing Trodelvy (sacituzumab govitecan-hziy) for eligible patients with cancer.
FDA has been taking a look at psychedelics as a potential treatment for psychiatric and substance abuse disorders, recently publishing a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA.
